	Ebitda		Date
Acadia Pharmaceuticals	USD 35.76M	447K	2025-09
Agios Pharmaceuticals	USD -115.49M	10.3M	2025-09
Akebia Therapeutics	USD 14.03M	17.19M	2025-03
Alnylam Pharmaceuticals	USD 145.22M	236.56M	2025-12
Amarin	USD 12.54M	28.57M	2025-06
Ardelyx	USD 5.57M	17.44M	2025-09
Astellas Pharma	JPY 183.68B	31.98B	2025-12
AstraZeneca	USD 5.23B	272M	2025-09
Charles River Laboratories	USD 258.06M	24.83M	2025-12
Coherus Biosciences	USD -44.34M	9.82M	2025-03
Esperion Therapeutics	USD -27.51M	9.5M	2023-09
Exact Sciences	USD 135.42M	2.8M	2025-09
Halozyme Therapeutics	USD 21.9M	226.34M	2025-12
Incyte	USD 414.5M	92.42M	2025-12
Ironwood Pharmaceuticals	USD 81.81M	31.71M	2025-09
Karyopharm Therapeutics	USD -26.2M	1.83M	2024-09
MacroGenics	USD 21.95M	55.39M	2025-09
Moderna	USD -790M	582M	2025-12
Myriad Genetics	USD 10.3M	4.2M	2025-09
Pacira	USD 38.71M	10.65M	2025-12
PTC Therapeutics	USD 20.63M	53.74M	2025-09
Puma Biotechnology	USD 729K	11.36M	2024-06
Sarepta Therapeutics	USD -168.03M	294.45M	2025-09
Takeda	JPY 448.13B	173.98B	2025-12
Ultragenyx Pharmaceutical	USD -156.79M	65.44M	2025-09
Vanda Pharmaceuticals	USD -8.31M	2.37M	2024-12

Ironwood Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.